Cargando…
Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study
BACKGROUND: Insulin is the recommend therapeutic agent of choice for the management of Cystic Fibrosis Related Diabetes (CFRD), despite only sub-optimal reductions in glycemic control and increased morbidity and mortality reported by centers using this agent. The newer insulin sensitizing agents dem...
Autores principales: | Onady, Gary M, Langdon, Leora J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513574/ https://www.ncbi.nlm.nih.gov/pubmed/16790062 http://dx.doi.org/10.1186/1472-6823-6-4 |
Ejemplares similares
-
An adult cystic fibrosis patient presenting with persistent dyspnea: case report
por: Onady, Gary M, et al.
Publicado: (2006) -
Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society
por: Moran, Antoinette, et al.
Publicado: (2010) -
Insulin Edema in a Patient With Cystic Fibrosis–Related Diabetes
por: O'Neal, Katherine S., et al.
Publicado: (2012) -
Insulin Therapy to Improve BMI in Cystic Fibrosis–Related Diabetes Without Fasting Hyperglycemia: Results of the Cystic Fibrosis Related Diabetes Therapy Trial
por: Moran, Antoinette, et al.
Publicado: (2009) -
Cystic Fibrosis-Related Diabetes
por: Kayani, Kayani, et al.
Publicado: (2018)